Skip to main navigation Skip to search Skip to main content

Bortezomib has anti-proliferative and apoptotic effects against CML stem cells, including the quiescent population

  • N. Heaney
  • , F. Pellicano
  • , Lisa Crawford
  • , Alexandra Irvine
  • , T.L. Holyoake

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)865A-865A
JournalBlood
Volume110
Publication statusPublished - Dec 2007

Cite this